Key result
Shengmai San lowers fructosamine and TNF-α in rats but fails to improve insulin resistance.
Why the study?
Shengmai San is prescribed for coronary heart disease, but its effects on high-fat diet-induced insulin resistance, inflammatory cytokine production, and oxidative stress required investigation.
Does Shengmai San improve insulin resistance, inflammation, and oxidative stress in male Wistar rats fed a high-fat diet?
Does Shengmai San improve insulin resistance, inflammation, and oxidative stress in male Wistar rats fed a high-fat diet?
Shengmai San exhibits anti-oxidative and anti-inflammatory properties but does not significantly reduce insulin resistance in a high-fat diet rat model.
Answers are grounded in this paper and cite their sources.
Shengmai San's anti-inflammatory effects in rats warrant clinical caution; leaves open its role in insulin resistance pending human trials.
Shengmai San (SMS) is a well-known traditional Chinese medicine formula prescribed for patients with coronary heart disease (CHD). Insulin resistance is the most likely explanation for the development and progression of this disease. To investigate the effect of SMS on high-fat diet-induced insulin resistance, inflammatory cytokine production and oxidative stress, male Wistar rats were fed with low-fat control diet, high-fat diet and high-fat diet supplemented with 4% SMS for eight weeks. An oral glucose tolerance test was conducted in the seventh week. Rats fed the SMS diet had significantly lower plasma fructosamine concentration (p < 0.05) and tended to have lower (p < 0.1) AUC values of plasma glucose and insulin concentrations after glucose challenge, compared to those fed the high-fat diet. Moreover, SMS reduced TNF-α and lipid peroxidation levels in the liver and heart. However, SMS had no effect on fasting plasma concentrations of glucose, insulin, triglyceride, non-esterified fatty acids, total cholesterol, HDL-cholesterol and insulin resistance index (homeostasis model assessment; HOMA) in rats. Our results show that SMS may have little or no significant effect on reducing insulin resistance, but display anti-oxidative and anti-inflammatory properties.
No takes yet. Share an insight, caveat, or question.
Yao et al. (2020) studied High-fat diet-induced insulin resistance. Shengmai San (SMS) vs. High-fat diet alone and low-fat control diet was evaluated on Plasma fructosamine concentration (p=<0.05). Shengmai San supplementation in high-fat diet-fed rats lowered plasma fructosamine (p<0.05) and reduced TNF-α and lipid peroxidation, but had no significant effect on insulin resistance.
Synapse has enriched 10 related papers. Consider them for comparative context: